Polymedco, Inc.

Polymedco is a B2B medical diagnostics company specializing in early detection and screening solutions for life-threatening diseases. The company develops and markets two primary product lines: OC-Auto® FIT, an automated fecal immunochemical test for colorectal cancer screening, and PATHFAST® Cardiac Biomarker Analyzer, a point-of-care (POC) cardiac testing platform. OC-Auto FIT is marketed as the number-one automated noninvasive CRC screening tool globally, carrying a Tier 1 US Preventive Services Task Force guideline recommendation, and has demonstrated clinical evidence of improving patient compliance (43.8% increase), reducing annual CRC incidence (25.5% reduction), and reducing cancer mortality (52.4% reduction). The PATHFAST analyzer performs lab-quality cardiac biomarker testing from a single whole blood sample, delivering results in minutes with measurements of Troponin I, NTproBNP, D-Dimer, hsCRP, CK-MB, and Myoglobin. Both systems are designed for integration into healthcare systems, reference laboratories, and point-of-care settings. Polymedco emphasizes customer-centric support, offering customizable programmatic solutions, technical implementation support, and LIS (Laboratory Information System) integration. The company partners with healthcare systems, payors, providers, and reference laboratories to improve screening accessibility and affordability. Products feature robust clinical evidence and user-friendly design for high-volume, cost-effective screening and diagnostic workflows.